Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Feb 14;206(3):101.
doi: 10.1007/s00203-023-03826-z.

Biofilm-mediated infections by multidrug-resistant microbes: a comprehensive exploration and forward perspectives

Affiliations
Review

Biofilm-mediated infections by multidrug-resistant microbes: a comprehensive exploration and forward perspectives

Mai M Zafer et al. Arch Microbiol. .

Abstract

A biofilm is a collection of microorganisms organized in a matrix of extracellular polymeric material. Biofilms consist of microbial cells that attach to both surfaces and each other, whether they are living or non-living. These microbial biofilms can lead to hospital-acquired infections and are generally detrimental. They possess the ability to resist the human immune system and antibiotics. The National Institute of Health (NIH) states that biofilm formation is associated with 65% of all microbial illnesses and 80% of chronic illnesses. Additionally, non-device-related microbial biofilm infections include conditions like cystic fibrosis, otitis media, infective endocarditis, and chronic inflammatory disorders. This review aims to provide an overview of research on chronic infections caused by microbial biofilms, methods used for biofilm detection, recent approaches to combat biofilms, and future perspectives, including the development of innovative antimicrobial strategies such as antimicrobial peptides, bacteriophages, and agents that disrupt biofilms.

Keywords: Antibiofilm strategies; Antibiotic resistance; Biofilm; Chronic infections; Future perspectives.

PubMed Disclaimer

Conflict of interest statement

The authors have no relevant financial or non-financial interests to disclose.

Figures

Fig. 1
Fig. 1
Cartoon representation of biofilm-mediated antibiotic resistance mechanisms
Fig. 2
Fig. 2
Schematic representation of the biofilm formation and their various detection techniques (phenotypic and genotypic)
Fig. 3
Fig. 3
Chemical structures of natural metabolites (112) with biofilm inhibitory potential
Fig. 4
Fig. 4
Chemical structures of natural metabolites (1318) with biofilm inhibitory potential
Fig. 5
Fig. 5
Representation of the advanced control strategies against biofilm and their possible mechanisms

References

    1. Alumutairi L, Yu B, Filka M, Nayfach J, Kim MH. Mild magnetic nanoparticle hyperthermia enhances the susceptibility of Staphylococcus aureus biofilm to antibiotics. Int J Hyperth. 2020;37(1):66–75. doi: 10.1080/02656736.2019.1707886. - DOI - PMC - PubMed
    1. Anand U, Jacobo-Herrera N, Altemimi A, Lakhssassi N. A comprehensive review on medicinal plants as antimicrobial therapeutics: potential avenues of biocompatible drug discovery. Metabolites. 2019;9(11):258. doi: 10.3390/METABO9110258. - DOI - PMC - PubMed
    1. And N, William Costerton D I, Cheng K-L, Geesey GG, Ladd TL, Dasgupta M, Marrie TI (1987) Bacterial biofilms in. Ann Rev Microbiol 41:43564 - PubMed
    1. Angrist AA, Oka M, Nakao K, Marquiss J. Studies in experimental endocarditis: I. Production of valvular lesions by mechanisms not involving infection or sensitivity factors. Am J Pathol. 1960;36(2):181. - PMC - PubMed
    1. Anwar H, Van Biesen T, Dasgupta M, Lam K, Costerton JW. Interaction of biofilm bacteria with antibiotics in a novel in vitro chemostat system. Antimicrob Agents Chemother. 1989;33(10):1824–1826. doi: 10.1128/AAC.33.10.1824. - DOI - PMC - PubMed

Substances